Canton Strategic Holdings

CNTN

Biotechnology · Healthcare

Price

$2.19

-0.02 (-0.90%)

Market Cap

$168.9M

Exchange

NASDAQ

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Share count rising — dilution

+105655.8% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 30K (2021) → 32.0M (2025)

Winston Score History

The full picture

Canton Strategic Holdings Inc is a small biotechnology company focused on developing drug candidates and therapeutic treatments. It operates in the healthcare sector, targeting diseases where there is a significant unmet medical need. The company is in an early stage of development, meaning it does not yet sell approved products to patients or hospitals.

The company's 100% gross margin reflects that it currently earns revenue from sources like licensing or grants rather than product sales, while its deeply negative operating margin shows it spends far more than it earns — a common pattern for pre-commercial biotech firms. Canton operates primarily in the United States and has a market capitalization of roughly $200 million. The main risk the business faces is running out of cash before it can advance its pipeline through clinical trials and regulatory approval, which requires sustained investment with no guarantee of success.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+87.5% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$3M/ year

↓ Declining (-52% vs prior year)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

17.7%ownership

↑ Rising

Insiders increasing their stake — aligned with shareholders

Cash Runway

~4 years

$37M cash & investments

Quarterly Free Cash Flow

$37M cash & investments at current burn rate

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

100.0%

Premium pricing power — 100.0% gross margin

Profit after running costs

Operating Margin

-80.4%

Losing money on operations — -80.4%

Return on the money invested

ROCE

-11.8%

Weak — -11.8% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

—

Data not available

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

8/8 quarters

Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

-1482.1%

Burning cash (-1482.1%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial